We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » GPhA: State Biosimilar Laws Could Have ‘Chilling Effect’
GPhA: State Biosimilar Laws Could Have ‘Chilling Effect’
January 25, 2013
Brand drugmakers are pushing states to enact legislation that could create hurdles for biosimilar substitution — a business move designed to hold on to profits, GPhA says.